Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT04193592 Not yet recruiting - Clinical trials for Interstitial Lung Disease

Efficacy and Safety of Pirfenidone Treatment in HPS-ILD

PEARL
Start date: December 1, 2019
Phase: Phase 2
Study type: Interventional

This research study will explore the safety and efficacy of the drug, pirfenidone, in patients with a diagnosis of Hermansky-Pudlak Syndrome (HPS) who have an associated interstitial lung disease (ILD) over a planned period of 56 weeks.

NCT ID: NCT04189367 Not yet recruiting - Clinical trials for Burning Mouth Syndrome

Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine

Start date: June 20, 2020
Phase: Phase 3
Study type: Interventional

This study is an open-label randomized controlled trial of the efficacy of the integration of Traditional Chinese medicine (TCM) and western medicine based on TCM syndrome differentiation. The hypothesis is (1) TCM model can identify the primary and secondary type burning mouth syndrome (BMS); (2) TCM model can identify BMS after treatment with western medicine; (3) There is a positive effect of TCM in treating BMS.

NCT ID: NCT04184583 Not yet recruiting - Clinical trials for Acute Coronary Syndrome

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Start date: December 2019
Phase:
Study type: Observational [Patient Registry]

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

NCT ID: NCT04179435 Not yet recruiting - Clinical trials for Tourette Syndrome in Adolescence

Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome

CADETS
Start date: December 2019
Phase: N/A
Study type: Interventional

In children with neurodevelopmental disorders, adolescence is usually associated with a reshaping of the clinical picture and symptomatology. Tourette syndrome (TS) is a paradigmal neurodevelopmental syndrome characterised by involuntary paroxysmal movements (motor tics) and vocalisation (vocal tics) often associated with various psychiatric disorders. The neuronal and cognitive mechanisms associated with TS symptoms improvement during adolescence, or the persistence in adulthood remains unknown, and this is what we aim to address in this study.

NCT ID: NCT04170166 Not yet recruiting - Clinical trials for Shoulder Subacromial Pain Syndrome

Subacromial Injections for Shoulder Subacromial Pain Syndrome - Anterolateral vs Posterior Approach

Start date: November 2019
Phase: N/A
Study type: Interventional

This study aims to determine if there is any difference in terms of pain relief in patients with shoulder subacromial pain syndrome, when given a steroid injection into the subacromial space via an anterolateral approach compared to a posterior approach.

NCT ID: NCT04168047 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?

S3i
Start date: July 2020
Phase: N/A
Study type: Interventional

Visceral hypersensitivity is frequent in IBS population up to 60% and is correlated with severity and altered quality of life. Sleeping troubles are most frequent in IBS population. Insomnia is a frequent disorder with an important cost for healthcare. Insomnia could decrease pain threshold. Visceral hypersensitivity was never measure in patients with insomnia. The hypothesis is IBS patients with insomnia probably have lower visceral pain threshold. The objective is to assess pain threshold during a barostat procedure in in IBS patients with or without insomnia in comparison with healthy volunteers or patients with insomnia. If the hypothesis are confirmed, insomnia should be look at in IBS patients and its treatments could improve visceral hypersensitivity and IBS symptoms.

NCT ID: NCT04152395 Not yet recruiting - Metabolic Syndrome Clinical Trials

Metabolic Syndrome in Patients Undergoing Endovascular Aortic Repair (EVAR)

Start date: June 1, 2020
Phase:
Study type: Observational

This prospective study aims to identify the prevalence of metabolic syndrome in patients undergoing EVAR and the implications of metabolic syndrome on the postoperative outcome, the major complications, the thromboembolic events and the perioperative mortality and morbidity of the patients undergoing vascular surgery.

NCT ID: NCT04150302 Not yet recruiting - Clinical trials for SBS - Short Bowel Syndrome

Development and Validation of a Questionnaire to Measure the Impact of SBS and Its Treatments on Patients' Lives

ARTEMIS_GC
Start date: January 2020
Phase:
Study type: Observational

Today, patients express a very strong need to take into account the consequences of their disease and its treatments in their therapeutic follow-up. It is therefore essential to better understand the needs, expectations and values of patients with SBS in order to better understand the impact of the disease on their lives, and thus improve the conditions for medical, social, psychological and technical care. The clinical expertise of health professionals and meetings with patient associations demonstrate the major gap between the parameters taken into account by physician to evaluate the evolution of the SBS and the day-to-day experience of the disease perceived by the patient. The objective of the ARTEMIS-GC study is to develop and validate an instrument to measure the impact of SBS and its treatments on daily life from the perspective of patients.

NCT ID: NCT04149886 Not yet recruiting - Sick Sinus Syndrome Clinical Trials

Cardiac Ganglionated Plexus Ablation Before Permanent Pacemaker Implantation in Patients With Sick Sinus Syndrome

GAPS
Start date: October 28, 2019
Phase: N/A
Study type: Interventional

Different studies for cardiac ganglionated plexus(GP) ablation to treat vagal vascular syncope, sinus node dysfunction, and functional atrioventricular block have been published. Investigators have developed a more specific approach of cardiac, called cardioneuroablation . This treatment is based on a high-frequency stimulation (HFS) and/or anatomical landmarks to identify GPs in left atrium,which being targeted by radiofrequency catheter ablation. The feasibility of GPs ablation/cardioneuroablation has already been tested in our center in former studies in humans,with a favorable outcome for the patients involved. The results of the former studies have been submitted for publication. However, there are no prospective randomized studies to evaluate the efficacy and safety of atrial ganglionated plexus ablation for SSS before permanent pacemaker implantation. The purpose of this study of GAPS in humans is to evaluate the efficacy and safety of cardioneuroablation in patients of sick sinus syndrome before they receive a permanent pacemaker.

NCT ID: NCT04142411 Not yet recruiting - Clinical trials for Carpal Tunnel Syndrome

Combined Effect of Insulin and Sodium Hyaluronate Injection Guided by Ultrasound in Carpal Tunnel Syndrome

PIT
Start date: November 2019
Phase: Early Phase 1
Study type: Interventional

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. The technique of perineural injection therapy (PIT) is now commonly used for peeling the nerve from surrounding soft tissue (called nerve hydrodissection), which may help to reduce neuro-inflammation, ischemic damage and allow impulse transmission. The objective of this study is to evaluate the efficacy of ultrasound guided insulin plus Sodium Hyaluronate injection in reducing symptoms caused by carpal tunnel syndrome.